Expression of PD-L1 clones (22C3 and 28-8) in hepatocellular carcinoma: a tertiary cancer care hospital experience

Background Hepatocellular carcinoma (HCC) is a highly aggressive and rapidly progressing form of cancer with a poor prognosis. Recent advances in the management of HCC focused on the novel immunotherapeutic modalities for patients with advanced disease. PD-L1 has emerged as a promising immunotherape...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Egyptian Liver Journal 2024-01, Vol.14 (1), p.4-7, Article 4
Hauptverfasser:	Asghar, Kashif, Bashir, Shaarif, Hassan, Muhammad, Farooq, Asim, Bakar, Muhammad Abu, Bilal, Sundus, Hameed, Maryam, Mehmood, Shafqat, Loya, Asif
Format:	Artikel
Sprache:	eng
Schlagworte:	22C3, 28-8 Biomarkers Cloning Epidemiology Hepatocellular carcinoma Hepatology Histopathology Immunotherapy Liver cancer Medicine Medicine & Public Health Metastasis Microbiology Original Research Article Pathology Programmed cell death ligand-1 Statistical analysis Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!